And more drug company shenanigans

New york times today shows that drug company shenanigans know no bounds (ie, not just in US!!).  Johnson and Johnson seems to have paid off Novartis to keep them from releasing a generic version of fentanyl in the Netherlands.  See link below.  Geoff
 
 

Comments

Post a Comment

if you would like to receive the near-daily emails regularly, please email me at gmodest@uphams.org

Popular posts from this blog

air pollution and heart disease

Yet another study found an increase in heart disease in people exposed to air pollution/fine-particulate matter exposure (see  cad air pollution lancet2016  in  dropbox , or doi.org/10.1016/ S0140-6736(16)00378-0). details: --6795 participants. aged 45-84, enrolled in the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) from 6 different US cities (Baltimore, Chicago, LA County, New York City, St Paul, Winston-Salem) --median age 62, 53% women, 39% white, 12% Chinese, 27% black, 22% Hispanic), 50-80% with at least some post-high school education, 15% smokers, BMI 28, 45% with hypertension and SBP 128 mmHg, 12% diabetic, 15% on statins and cholesterol/HDL/LDL=190/50/115 --followed 10 years with repeated measurements of coronary artery calcium by CT (CAC score) as well as carotid artery intima-media thickness (CIMT); concentrations of fine particulate matter (PM 2.5 , which refle...
Read more

resistant hypertension: are diuretics harmful?

Image
  i decided to comment extensively on a very recent review article that supports the quite provocative argument that we are treating hypertension incorrectly, especially treatment-resistant hypertension, and that we should avoid the early use of the typical diuretics and instead use spironolactone much earlier in the cascade of meds. this pretty brief article is well-referenced (59 references) to support each of their points and to justify their proposed paradigm-shift in hypertension treatment (see   htn resistant diuretics harmful HTN2025  in dropbox, or . DOI: 10.1161/HYPERTENSIONAHA.125.24871): -- treatment-resistant hypertension (TRH) has historically been defined as the failure to achieve the recommended blood pressure with at least 3 classes of antihypertensive meds, including a diuretic, at target or maximally tolerated doses     -- in general, the diuretics used are thiazides or chlorthalidone unless there is significant renal failure, when loop di...
Read more

Body Roundness Index is better predictor than BMI for clinical problems

  A recent study found that the Body Roundness Index (BRI) is a better predictor of adverse clinical effects than Body Mass Index (BMI), our usual surrogate marker for obesity-related adverse outcomes (see  obesity body roundness index JAMA2024  in dropbox, or doi:10.1001/jamanetworkopen.2024.15051)   Details: --32,995 US adults >20yo selected  from the National Health and Nutrition Examination Survey (NHANES) were evaluated for the relationship between Body Roundness Index (BRI) and all-cause mortality, with mortality data derived from the CDC website and linked to the NHANES database     -- since 1999, NHANES conducted surveys every 2 years based on in-home interviews and study visits; 10 cycles from 1999-2018 were included. Nonpregnant individuals were selected to be representative of the noninstitutionalized civilian population     -- BRI was calculated as: 364.2 − 365.5 × √ 1 − [waist circumference in cen...
Read more